BioCentury
ARTICLE | Company News

Mercator Therapeutics, Pepscan Therapeutics deal

January 10, 2011 8:00 AM UTC

Pepscan will use its Chemical LInkage of Peptides onto Scaffolds (CLIPS) technology to optimize homing peptide-drug conjugates from Mercator. Mercator said the peptides bind to receptors that are high...